Clinical Trial Update: Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis [NA]

View source ↗

Summary

Update on a clinical trial evaluating low-molecular-weight heparin for deep venous thrombosis prophylaxis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Venous Thrombosis

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University of Tennessee | Conditions: Deep Venous Thrombosis | NA | Status: UNKNOWN